Outlook Therapeutics OTLK
NASDAQ OTLK
$0.48 +0.02 (+4.43%)
At close: Nov 11, 2026 · 4:00 PM EST

Outlook Therapeutics (OTLK) Current Leases (2015 - 2026)

Updated

Outlook Therapeutics (OTLK) recorded Current Leases of $1,084 in fiscal Q1 2024 (quarter ended Dec 31, 2023), down 91.1% from $12,137 a year earlier and down 74.6% from the prior quarter.

Analysis

Outlook Therapeutics (OTLK) Current Leases (2015 - 2026) Analysis & Trends

At the end of FY2023 (ended Sep 30, 2023), Outlook Therapeutics reported Current Leases of $4,267, down 63.7% from FY2022.

  • Annual Current Leases has declined for five straight fiscal years, with a five-year compound annual growth rate of -61.7% (FY2018 to FY2023).
  • Across earlier fiscal years, Current Leases came in at $11,751 in FY2022 (-55.6%), $26,464 in FY2021 (-11.1%), $29,778 in FY2020 (-84.5%) and $192,290 in FY2019 (-63.1%).
  • The fiscal Q1 2024 figure is the lowest quarterly Current Leases in data going back to fiscal Q4 2015.
  • On a year-over-year basis, Current Leases has declined for 20 consecutive quarters, with an average decline of 53.6% over the last eight quarters.
  • Across the past five years, year-over-year decline in Current Leases ran from 11.1% in fiscal Q4 2021 to 91.1% in fiscal Q1 2024.
  • Per Business Quant, the preceding three fiscal quarters came in at $4,267 (Q4 2023), $7,349 (Q3 2023) and $10,332 (Q2 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Outlook Therapeutics 62.90 Mn 27.15 Mn -8,265.00 64,016.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 64,016.00
Mar 31, 2026 62,003.00
Dec 31, 2025 61,125.00
Sep 30, 2025 58,897.00
Jun 30, 2025 56,560.00
Mar 31, 2025 54,425.00
Dec 31, 2024 52,645.00
Sep 30, 2024 50,907.00
Jun 30, 2024 31,801.00
Dec 31, 2023 1,084.00
Sep 30, 2023 4,267.00
Jun 30, 2023 7,349.00
Mar 31, 2023 10,332.00
Dec 31, 2022 12,137.00
Sep 30, 2022 11,751.00
Jun 30, 2022 14,354.00
Mar 31, 2022 18,422.00
Dec 31, 2021 22,460.00
Sep 30, 2021 26,464.00
Jun 30, 2021 27,459.00
API Access

Outlook Therapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=OTLK&period=max&api_key=YOUR_API_KEY